Skip Navigation

Annals of Oncology 2008 19(11):1819; doi:10.1093/annonc/mdn704
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

in this issue

in this issue

The first 10% of the full text of this article appears below.


   CNS relapse related to adjuvant taxane treatment in node-positive breast cancer
 
Node-positive breast cancer is a disease with a significant risk of relapse and death. Anthracycline-containing adjuvant chemotherapy has been shown to increase disease-free survival (DFS) and overall survival. However, breast cancer central nervous system (CNS) metastases are an increasingly important problem because of high CNS relapse rates in patients treated with trastuzumab and/or taxanes. In this issue, Pestalozzi et al. [pp. 1837–1842], . . . [Full Text of this Article]


   Telomere shortening, DNA damage response and telomeric protein downregulation in colorectal preneoplastic lesions
 

   CD5 expression as a predictor of outcome in patients with DLBCL receiving rituximab plus CHOP therapy
 

   Euthanasia, life sustaining treatment and acceleration of death
 

   Quote
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?